Use of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis

The HEART Pathway combines a decision aid and serial contemporary cardiac troponin I (cTnI) measures to achieve >99% sensitivity for major adverse cardiac events (MACE) at 30days and early discharge rates >20%. However, the impact of integrating high-sensitivity troponin (hs-cTn) measures into...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical biochemistry Vol. 50; no. 7-8; pp. 401 - 407
Main Authors:	Mahler, Simon A., Stopyra, Jason P., Apple, Fred S., Riley, Robert F., Russell, Gregory B., Hiestand, Brian C., Hoekstra, James W., Lefebvre, Cedric W., Nicks, Bret A., Cline, David M., Askew, Kim L., Herrington, David M., Burke, Gregory L., Miller, Chadwick D.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01-05-2017
Subjects:	Acute coronary syndrome Adult Aged Chest pain Female HEART Pathway Humans Male Middle Aged Myocardial Infarction - blood Predictive Value of Tests Troponin Troponin C - blood RCT NRI CI Chest pain HEART Pathway EMR ADP URL ACS Troponin MACE NPV hs-cTn cTn MI Acute coronary syndrome ED
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!